Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

merck_sharp_dohme_deepak_khanna

MSD’s Deepak Khanna to chair American Pharmaceutical Group

March 17, 2011 Research and Development, Sales and Marketing American Pharmaceutical Group, Deepak Khanna, MSD, merck sharp and dohme

Merck Sharp and Dohme’s UK managing director Deepak Khanna has been appointed chairman of the American Pharmaceutical Group. The APG …
Appointment
novartis

Novartis to close UK manufacturing site, research downsized

March 16, 2011 Research and Development Horsham, Novartis, respiratory

Novartis is to close its manufacturing site in Horsham, West Sussex, but will retain its work in respiratory research at …
News
Novarits

Novartis to close UK research site

March 16, 2011 Research and Development Horsham, Novartis, job cuts, pharma job cuts

[UPDATE: Novartis has confirmed it will close its manufacturing site in Horsham, but continue to conduct respiratory research at the site …
News

New Regulatory & Pharmacovigilance training webinars available

March 15, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Wainwright Associates have designed a multitude of courses on general and specific regulatory & pharmacovigilance topics including:• Analytical Validation• Appeals, Hearings and …
News
Press release
Pfizer's Sandwich research facility

Pfizer’s CRO plans for Sandwich will have limited impact

March 15, 2011 Business Services, Research and Development Jobs, Kent, Pfizer, Sandwich, job cuts

Pfizer’s efforts to attract contract research organisations to take over part of its Sandwich research site will only benefit a …
News

Bayer-helmed oncology biomarker project launched

March 14, 2011 Manufacturing and Production, Research and Development AstraZeneca, Bayer, Janssen, Max Planck Institute, Merck, OncoTrack, Pfizer, Roche, biomarkers, oncology

A project to develop the next generation of oncology biomarkers has been launched in Berlin. The pharma industry and European …
News

Diabetes trial disappointment for GSK and Tolerx

March 14, 2011 Research and Development DEFEND-1, DEFEND-2, GSK, GlaxoSmithKline, Tolerx, diabetes, otelixizumab, type I diabetes

GSK and Tolerx’s type I diabetes drug otelixizumab has failed to meet its primary endpoint in a late-stage trial. Anti-CD3 …
News

Former Gates Foundation director joins Sanofi

March 14, 2011 Research and Development Dr Richard Klausner, Sanofi-Aventis, appointment, research and development

Sanofi-Aventis has appointed a former Gates Foundation director to chair its strategic development and scientific advisory council. Dr Richard Klausner …
News

Sanofi lung cancer drug fails in late-stage trial

March 11, 2011 Research and Development Cancer, NSCLC, Regeneron, Sanofi-Aventis, aflibercept, non-small cell lung cancer

Sanofi-Aventis’ lung cancer drug aflibercept has failed to meet its primary endpoint in a phase III trial. The late-stage VITAL …
News

Tangles and plaques: unlocking the secrets of Alzheimer’s disease

March 11, 2011 Research and Development, Sales and Marketing Alzheimer's, Alzheimer's disease, bapineuzumab, dimebon, latrepirdine, solanezumab

Despite many years of relentless research efforts, Alzheimer’s disease, the most common form of dementia, remains impossible to cure. According …
Feature

‘This R&D Malarkey, it’s broken, isn’t it?’

March 9, 2011 Research and Development R&D, Sandwich, research productivity

Pharmaceutical industry leaders are increasingly admitting that the very low productivity of its R&D pipelines is unsustainable – but no …
Feature

Francois Meyer to head up TxCell

March 9, 2011 Research and Development Francois Meyer, TxCell, appointment, research and development

French biotech TxCell has appointed François Meyer as chief executive. He has more than 25 years of pharma and biotech …
Appointment
AstraZeneca

AZ partners with Galderma on psoriasis research

March 9, 2011 Research and Development AZ, AstraZeneca, Galderma, dermatology, psoriasis

AstraZeneca has signed a five-year deal with dermatology specialist Galderma Pharma to develop new treatments for conditions including psoriasis. It …
News

Eisai confirms 20% cut in US workforce

March 8, 2011 Manufacturing and Production, Research and Development, Sales and Marketing Aricept, Eisai, Halaven, US, donepezil, eribulin, pharma job cuts

Eisai’s planned job cuts will fall heaviest on its US operations, where 20% of the workforce will be let go …
News
Merck & Co workers protest job cuts

Merck says sale of Oss facility would be too expensive

March 8, 2011 Manufacturing and Production, Research and Development Holland, Merck & Co, Oss, Oss pharma research, Pantarhei Bioscience

The debate around the closure of Merck & Co’s R&D and manufacturing unit in Oss, the Netherlands, rumbles on, with …
News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026